- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Opioid Induced Constipation Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Opioid Induced Constipation Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Opioid Induced Constipation Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Opioid Induced Constipation Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Opioid Induced Constipation Drugs market are listed below:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Opioid Induced Constipation Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Induced Constipation Drugs, with price, sales, revenue and global market share of Opioid Induced Constipation Drugs from 2019 to 2021.
Chapter 3, the Opioid Induced Constipation Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Induced Constipation Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Opioid Induced Constipation Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Opioid Induced Constipation Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Opioid Induced Constipation Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioid Induced Constipation Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioid Induced Constipation Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Opioid Induced Constipation Drugs Market Size & Forecast
1.4.1 Global Opioid Induced Constipation Drugs Sales in Value (2016-2026))
1.4.2 Global Opioid Induced Constipation Drugs Sales in Volume (2016-2026)
1.4.3 Global Opioid Induced Constipation Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Opioid Induced Constipation Drugs Production Capacity Analysis
1.5.1 Global Opioid Induced Constipation Drugs Total Production Capacity (2016-2026)
1.5.2 Global Opioid Induced Constipation Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioid Induced Constipation Drugs Market Drivers
1.6.2 Opioid Induced Constipation Drugs Market Restraints
1.6.3 Opioid Induced Constipation Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Ironwood Pharmaceuticals Inc
2.1.1 Ironwood Pharmaceuticals Inc Details
2.1.2 Ironwood Pharmaceuticals Inc Major Business
2.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Services
2.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Daiichi Sankyo Co Ltd
2.2.1 Daiichi Sankyo Co Ltd Details
2.2.2 Daiichi Sankyo Co Ltd Major Business
2.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product and Services
2.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Opioid Induced Constipation Drugs Product and Services
2.3.4 Pfizer Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Progenics Pharmaceuticals Inc
2.4.1 Progenics Pharmaceuticals Inc Details
2.4.2 Progenics Pharmaceuticals Inc Major Business
2.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Services
2.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Shionogi & Co., Ltd
2.5.1 Shionogi & Co., Ltd Details
2.5.2 Shionogi & Co., Ltd Major Business
2.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product and Services
2.5.4 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Allergan Plc
2.6.1 Allergan Plc Details
2.6.2 Allergan Plc Major Business
2.6.3 Allergan Plc Opioid Induced Constipation Drugs Product and Services
2.6.4 Allergan Plc Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Nektar Therapeutics
2.7.1 Nektar Therapeutics Details
2.7.2 Nektar Therapeutics Major Business
2.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Product and Services
2.7.4 Nektar Therapeutics Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Purdue Pharma
2.8.1 Purdue Pharma Details
2.8.2 Purdue Pharma Major Business
2.8.3 Purdue Pharma Opioid Induced Constipation Drugs Product and Services
2.8.4 Purdue Pharma Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 S.L.A. Pharma AG
2.9.1 S.L.A. Pharma AG Details
2.9.2 S.L.A. Pharma AG Major Business
2.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Product and Services
2.9.4 S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Mundipharma International Limited
2.10.1 Mundipharma International Limited Details
2.10.2 Mundipharma International Limited Major Business
2.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Product and Services
2.10.4 Mundipharma International Limited Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Ono Pharmaceutical Co., Ltd
2.11.1 Ono Pharmaceutical Co., Ltd Details
2.11.2 Ono Pharmaceutical Co., Ltd Major Business
2.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product and Services
2.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business
2.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product and Services
2.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Theravance Biopharma Inc
2.13.1 Theravance Biopharma Inc Details
2.13.2 Theravance Biopharma Inc Major Business
2.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Product and Services
2.13.4 Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Bausch Health
2.14.1 Bausch Health Details
2.14.2 Bausch Health Major Business
2.14.3 Bausch Health Opioid Induced Constipation Drugs Product and Services
2.14.4 Bausch Health Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Cosmo Pharmaceuticals SA
2.15.1 Cosmo Pharmaceuticals SA Details
2.15.2 Cosmo Pharmaceuticals SA Major Business
2.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product and Services
2.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Daewoong Pharmaceutical
2.16.1 Daewoong Pharmaceutical Details
2.16.2 Daewoong Pharmaceutical Major Business
2.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product and Services
2.16.4 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 C.B. Fleet Company
2.17.1 C.B. Fleet Company Details
2.17.2 C.B. Fleet Company Major Business
2.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Product and Services
2.17.4 C.B. Fleet Company Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Sucampo Pharmaceuticals
2.18.1 Sucampo Pharmaceuticals Details
2.18.2 Sucampo Pharmaceuticals Major Business
2.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product and Services
2.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Opioid Induced Constipation Drugs Sales by Manufacturer
3.1 Global Opioid Induced Constipation Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Opioid Induced Constipation Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Opioid Induced Constipation Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Opioid Induced Constipation Drugs Manufacturer Market Share
3.4.2 Top 6 Opioid Induced Constipation Drugs Manufacturer Market Share
3.5 Global Opioid Induced Constipation Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Opioid Induced Constipation Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Opioid Induced Constipation Drugs Market Size by Region
4.1.1 Global Opioid Induced Constipation Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Opioid Induced Constipation Drugs Revenue by Region (2016-2026)
4.2 North America Opioid Induced Constipation Drugs Revenue (2016-2026)
4.3 Europe Opioid Induced Constipation Drugs Revenue (2016-2026)
4.4 Asia-Pacific Opioid Induced Constipation Drugs Revenue (2016-2026)
4.5 South America Opioid Induced Constipation Drugs Revenue (2016-2026)
4.6 Middle East and Africa Opioid Induced Constipation Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Opioid Induced Constipation Drugs Sales in Volume by Type (2016-2026)
5.2 Global Opioid Induced Constipation Drugs Revenue by Type (2016-2026)
5.3 Global Opioid Induced Constipation Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Opioid Induced Constipation Drugs Sales in Volume by Application (2016-2026)
6.2 Global Opioid Induced Constipation Drugs Revenue by Application (2016-2026)
6.3 Global Opioid Induced Constipation Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Opioid Induced Constipation Drugs Sales by Type (2016-2026)
7.2 North America Opioid Induced Constipation Drugs Sales by Application (2016-2026)
7.3 North America Opioid Induced Constipation Drugs Market Size by Country
7.3.1 North America Opioid Induced Constipation Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Opioid Induced Constipation Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Opioid Induced Constipation Drugs Sales by Type (2016-2026)
8.2 Europe Opioid Induced Constipation Drugs Sales by Application (2016-2026)
8.3 Europe Opioid Induced Constipation Drugs Market Size by Country
8.3.1 Europe Opioid Induced Constipation Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Opioid Induced Constipation Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Opioid Induced Constipation Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Opioid Induced Constipation Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Opioid Induced Constipation Drugs Market Size by Region
9.3.1 Asia-Pacific Opioid Induced Constipation Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Opioid Induced Constipation Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Opioid Induced Constipation Drugs Sales by Type (2016-2026)
10.2 South America Opioid Induced Constipation Drugs Sales by Application (2016-2026)
10.3 South America Opioid Induced Constipation Drugs Market Size by Country
10.3.1 South America Opioid Induced Constipation Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Opioid Induced Constipation Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Opioid Induced Constipation Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Opioid Induced Constipation Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Opioid Induced Constipation Drugs Market Size by Country
11.3.1 Middle East & Africa Opioid Induced Constipation Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Opioid Induced Constipation Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Opioid Induced Constipation Drugs Typical Distributors
12.3 Opioid Induced Constipation Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Opioid Induced Constipation Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Opioid Induced Constipation Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Ironwood Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 4. Ironwood Pharmaceuticals Inc Major Business
Table 5. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Services
Table 6. Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Co Ltd Major Business
Table 9. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Product and Services
Table 10. Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Opioid Induced Constipation Drugs Product and Services
Table 14. Pfizer Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Progenics Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 16. Progenics Pharmaceuticals Inc Major Business
Table 17. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Product and Services
Table 18. Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Shionogi & Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Shionogi & Co., Ltd Major Business
Table 21. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Product and Services
Table 22. Shionogi & Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Allergan Plc Basic Information, Manufacturing Base and Competitors
Table 24. Allergan Plc Major Business
Table 25. Allergan Plc Opioid Induced Constipation Drugs Product and Services
Table 26. Allergan Plc Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Nektar Therapeutics Major Business
Table 29. Nektar Therapeutics Opioid Induced Constipation Drugs Product and Services
Table 30. Nektar Therapeutics Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 32. Purdue Pharma Major Business
Table 33. Purdue Pharma Opioid Induced Constipation Drugs Product and Services
Table 34. Purdue Pharma Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. S.L.A. Pharma AG Basic Information, Manufacturing Base and Competitors
Table 36. S.L.A. Pharma AG Major Business
Table 37. S.L.A. Pharma AG Opioid Induced Constipation Drugs Product and Services
Table 38. S.L.A. Pharma AG Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mundipharma International Limited Basic Information, Manufacturing Base and Competitors
Table 40. Mundipharma International Limited Major Business
Table 41. Mundipharma International Limited Opioid Induced Constipation Drugs Product and Services
Table 42. Mundipharma International Limited Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Ono Pharmaceutical Co., Ltd Major Business
Table 45. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Product and Services
Table 46. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Pharmaceutical Company Limited Major Business
Table 49. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Product and Services
Table 50. Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Theravance Biopharma Inc Basic Information, Manufacturing Base and Competitors
Table 52. Theravance Biopharma Inc Major Business
Table 53. Theravance Biopharma Inc Opioid Induced Constipation Drugs Product and Services
Table 54. Theravance Biopharma Inc Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 56. Bausch Health Major Business
Table 57. Bausch Health Opioid Induced Constipation Drugs Product and Services
Table 58. Bausch Health Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Cosmo Pharmaceuticals SA Basic Information, Manufacturing Base and Competitors
Table 60. Cosmo Pharmaceuticals SA Major Business
Table 61. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Product and Services
Table 62. Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Daewoong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Daewoong Pharmaceutical Major Business
Table 65. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Product and Services
Table 66. Daewoong Pharmaceutical Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. C.B. Fleet Company Basic Information, Manufacturing Base and Competitors
Table 68. C.B. Fleet Company Major Business
Table 69. C.B. Fleet Company Opioid Induced Constipation Drugs Product and Services
Table 70. C.B. Fleet Company Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 72. Sucampo Pharmaceuticals Major Business
Table 73. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Product and Services
Table 74. Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Opioid Induced Constipation Drugs Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 76. Global Opioid Induced Constipation Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Opioid Induced Constipation Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Opioid Induced Constipation Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 79. Head Office and Opioid Induced Constipation Drugs Production Site of Key Manufacturer
Table 80. Opioid Induced Constipation Drugs New Entrant and Capacity Expansion Plans
Table 81. Opioid Induced Constipation Drugs Mergers & Acquisitions in the Past Five Years
Table 82. Global Opioid Induced Constipation Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 83. Global Opioid Induced Constipation Drugs Sales by Region (2021-2026) & (K Pcs)
Table 84. Global Opioid Induced Constipation Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Opioid Induced Constipation Drugs Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Opioid Induced Constipation Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 87. Global Opioid Induced Constipation Drugs Sales by Type (2021-2026) & (K Pcs)
Table 88. Global Opioid Induced Constipation Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Opioid Induced Constipation Drugs Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Opioid Induced Constipation Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 91. Global Opioid Induced Constipation Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 92. Global Opioid Induced Constipation Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 93. Global Opioid Induced Constipation Drugs Sales by Application (2021-2026) & (K Pcs)
Table 94. Global Opioid Induced Constipation Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Opioid Induced Constipation Drugs Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Opioid Induced Constipation Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 97. Global Opioid Induced Constipation Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 98. North America Opioid Induced Constipation Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 99. North America Opioid Induced Constipation Drugs Sales by Country (2021-2026) & (K Pcs)
Table 100. North America Opioid Induced Constipation Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Opioid Induced Constipation Drugs Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Opioid Induced Constipation Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 103. North America Opioid Induced Constipation Drugs Sales by Type (2021-2026) & (K Pcs)
Table 104. North America Opioid Induced Constipation Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 105. North America Opioid Induced Constipation Drugs Sales by Application (2021-2026) & (K Pcs)
Table 106. Europe Opioid Induced Constipation Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 107. Europe Opioid Induced Constipation Drugs Sales by Country (2021-2026) & (K Pcs)
Table 108. Europe Opioid Induced Constipation Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Opioid Induced Constipation Drugs Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Opioid Induced Constipation Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 111. Europe Opioid Induced Constipation Drugs Sales by Type (2021-2026) & (K Pcs)
Table 112. Europe Opioid Induced Constipation Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 113. Europe Opioid Induced Constipation Drugs Sales by Application (2021-2026) & (K Pcs)
Table 114. Asia-Pacific Opioid Induced Constipation Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 115. Asia-Pacific Opioid Induced Constipation Drugs Sales by Region (2021-2026) & (K Pcs)
Table 116. Asia-Pacific Opioid Induced Constipation Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Opioid Induced Constipation Drugs Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Opioid Induced Constipation Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 119. Asia-Pacific Opioid Induced Constipation Drugs Sales by Type (2021-2026) & (K Pcs)
Table 120. Asia-Pacific Opioid Induced Constipation Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 121. Asia-Pacific Opioid Induced Constipation Drugs Sales by Application (2021-2026) & (K Pcs)
Table 122. South America Opioid Induced Constipation Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 123. South America Opioid Induced Constipation Drugs Sales by Country (2021-2026) & (K Pcs)
Table 124. South America Opioid Induced Constipation Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Opioid Induced Constipation Drugs Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Opioid Induced Constipation Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 127. South America Opioid Induced Constipation Drugs Sales by Type (2021-2026) & (K Pcs)
Table 128. South America Opioid Induced Constipation Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 129. South America Opioid Induced Constipation Drugs Sales by Application (2021-2026) & (K Pcs)
Table 130. Middle East & Africa Opioid Induced Constipation Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 131. Middle East & Africa Opioid Induced Constipation Drugs Sales by Country (2021-2026) & (K Pcs)
Table 132. Middle East & Africa Opioid Induced Constipation Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Opioid Induced Constipation Drugs Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Opioid Induced Constipation Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 135. Middle East & Africa Opioid Induced Constipation Drugs Sales by Type (2021-2026) & (K Pcs)
Table 136. Middle East & Africa Opioid Induced Constipation Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 137. Middle East & Africa Opioid Induced Constipation Drugs Sales by Application (2021-2026) & (K Pcs)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Opioid Induced Constipation Drugs Typical Distributors
Table 141. Opioid Induced Constipation Drugs Typical Customers
List of Figures
Figure 1. Opioid Induced Constipation Drugs Picture
Figure 2. Global Opioid Induced Constipation Drugs Sales Market Share by Type in 2020
Figure 3. Lubiprostone
Figure 4. Methyl Naltrexone Bromide
Figure 5. Naldemedine
Figure 6. Alvimopan
Figure 7. Others
Figure 8. Global Opioid Induced Constipation Drugs Sales Market Share by Application in 2020
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Opioid Induced Constipation Drugs Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Opioid Induced Constipation Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Opioid Induced Constipation Drugs Sales (2016-2026) & (K Pcs)
Figure 15. Global Opioid Induced Constipation Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Opioid Induced Constipation Drugs Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Opioid Induced Constipation Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Opioid Induced Constipation Drugs Market Drivers
Figure 19. Opioid Induced Constipation Drugs Market Restraints
Figure 20. Opioid Induced Constipation Drugs Market Trends
Figure 21. Global Opioid Induced Constipation Drugs Sales Market Share by Manufacturer in 2020
Figure 22. Global Opioid Induced Constipation Drugs Revenue Market Share by Manufacturer in 2020
Figure 23. Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Opioid Induced Constipation Drugs Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Opioid Induced Constipation Drugs Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Opioid Induced Constipation Drugs Sales Market Share by Region (2016-2026)
Figure 27. Global Opioid Induced Constipation Drugs Revenue Market Share by Region (2016-2026)
Figure 28. North America Opioid Induced Constipation Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Europe Opioid Induced Constipation Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Opioid Induced Constipation Drugs Revenue (2016-2026) & (USD Million)
Figure 31. South America Opioid Induced Constipation Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Opioid Induced Constipation Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Global Opioid Induced Constipation Drugs Sales Market Share by Type (2016-2026)
Figure 34. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2016-2026)
Figure 35. Global Opioid Induced Constipation Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Opioid Induced Constipation Drugs Sales Market Share by Application (2016-2026)
Figure 37. Global Opioid Induced Constipation Drugs Revenue Market Share by Application (2016-2026)
Figure 38. Global Opioid Induced Constipation Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Opioid Induced Constipation Drugs Sales Market Share by Type (2016-2026)
Figure 40. North America Opioid Induced Constipation Drugs Sales Market Share by Application (2016-2026)
Figure 41. North America Opioid Induced Constipation Drugs Sales Market Share by Country (2016-2026)
Figure 42. North America Opioid Induced Constipation Drugs Revenue Market Share by Country (2016-2026)
Figure 43. United States Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Opioid Induced Constipation Drugs Sales Market Share by Type (2016-2026)
Figure 47. Europe Opioid Induced Constipation Drugs Sales Market Share by Application (2016-2026)
Figure 48. Europe Opioid Induced Constipation Drugs Sales Market Share by Country (2016-2026)
Figure 49. Europe Opioid Induced Constipation Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Opioid Induced Constipation Drugs Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Opioid Induced Constipation Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Opioid Induced Constipation Drugs Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Opioid Induced Constipation Drugs Revenue Market Share by Region (2016-2026)
Figure 59. China Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Opioid Induced Constipation Drugs Sales Market Share by Type (2016-2026)
Figure 66. South America Opioid Induced Constipation Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Opioid Induced Constipation Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Opioid Induced Constipation Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Opioid Induced Constipation Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Opioid Induced Constipation Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Opioid Induced Constipation Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
